← Назад

Homozygous familial hypercholesterolemia

ORPHA:391665DiseaseAutosomal dominant, Autosomal recessiveNeonatal

Ассоциированные гены (6)

ABCG5
ATP binding cassette subfamily G member 5
Candidate gene tested in
OMIM: 605459
ABCG8
ATP binding cassette subfamily G member 8
Candidate gene tested in
OMIM: 605460
APOB
apolipoprotein B
Disease-causing germline mutation(s) in
OMIM: 107730
LDLRAP1
low density lipoprotein receptor adaptor protein 1
Disease-causing germline mutation(s) in
OMIM: 605747
PCSK9
proprotein convertase subtilisin/kexin type 9
Disease-causing germline mutation(s) in
OMIM: 607786
LDLR
low density lipoprotein receptor
Disease-causing germline mutation(s) in
OMIM: 606945

Фенотипы (33)

Облигатный (100%)3
HP:0003077Hyperlipidemia
HP:0003124Hypercholesterolemia
HP:0003141Increased LDL cholesterol concentration
Очень частый (80–99%)2
HP:0004416Precocious atherosclerosis
HP:0005177Premature arteriosclerosis
Частый (30–79%)17
HP:0000822Hypertension
HP:0001397Hepatic steatosis
HP:0001645Sudden cardiac death
HP:0001658Myocardial infarction
HP:0001677Coronaryartery atherosclerosis
HP:0001681Angina pectoris
HP:0001920Renal artery stenosis
HP:0002094Dyspnea
HP:0004950Peripheral arterial stenosis
HP:0005162Abnormal left ventricular function
HP:0005181Premature coronary artery atherosclerosis
HP:0006693Myocardial steatosis
HP:0007201Cerebral artery atherosclerosis
HP:0012397Aortic atherosclerosis
HP:0030148Heart murmur
HP:0100261Abnormal tendon morphology
HP:3000062Abnormal internal carotid artery morphology
Периодический (5–29%)7
HP:0000799Renal steatosis
HP:0000991Xanthomatosis
HP:0001653Mitral regurgitation
HP:0002829Arthralgia
HP:0004381Supravalvular aortic stenosis
HP:0004963Calcification of the aorta
HP:0010874Tendon xanthomatosis
Очень редкий (1–4%)4
HP:0001138Optic neuropathy
HP:0012373Abnormal eye physiology
HP:0012638Abnormality of nervous system physiology
HP:0030882Coronary artery aneurysm

Эпидемиология (6)

Annual incidence
1-9 / 1 000 000
Japan
Point prevalence
1-9 / 1 000 000
Worldwide
Point prevalence
1-9 / 1 000 000
Spain
Point prevalence
1-9 / 1 000 000
Denmark
Point prevalence
1-9 / 1 000 000
Netherlands
Point prevalence
1-9 / 1 000 000
Germany

Лекарства и терапия

Источник: Open Targets Platform (в реальном времени)

Клинические исследования

Источник: ClinicalTrials.gov (в реальном времени)

Внешние ресурсы